Giancarlo Barolat Romana
Neurological Surgery · Denver, CONPI 1437212404
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 51.7% of the total. Reporting peaked in 2020 at $28,786 and has fallen 85.1% since, to $4,300 in 2025.
Across 198 payments — averaging $320.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$33K
- Nevro Corp.$10K
- GSK$9K
- Saluda Medical Americas, Inc.$3K
- International Rehabilitative Sciences, Inc$3K
- Medtronic$2K
- plus $3K from 13 others
Across 3 payments — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$75K
Across 7 payments — averaging $23,998 each. An ownership or investment interest held by the physician or an immediate family member.
- SPR Therapeutics, Inc$168K
What the payments were for
- Consulting fees$19,55531%
- Speaking & faculty fees$26,40042%
- Travel & lodging$3,7276%
- Food & beverage$10,77217%
- Other$2,9455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 85 | $32,759 |
| Nevro Corp. | 18 | $10,268 |
| GSK | 6 | $8,805 |
| Saluda Medical Americas, Inc. | 12 | $3,497 |
| International Rehabilitative Sciences, Inc | 3 | $3,279 |
| Medtronic(2 entities) | 26 | $1,738 |
| MML US, Inc. | 10 | $1,060 |
| Abbott | 15 | $859 |
| SPR Therapeutics, Inc | 8 | $534 |
| Biocomposites Inc | 2 | $183 |
| Nalu Medical, Inc. | 2 | $103 |
| AbbVie | 1 | $98 |
| Curonix LLC | 4 | $64 |
| Painteq LLC | 1 | $37 |
| Axonics, Inc. | 1 | $32 |
| Stimwave Technologies Incorporated | 1 | $28 |
| Pfizer | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| BD | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$28,484
- Senza Spinal Cord Stimulation System$9,935
- RS 4i Plus Sequential Stimulator$3,185
- Evoke$2,967
- RS-FBG, RS LBG GARMENT$2,945
- ReActiv8$970
- GENERAL PAIN MANAGEMENT$581
- GENERAL KIDNEY STONE DISEASE$544
- ETERNA$435
- INTELLIS ADAPTIVESTIM$415
- SPRINT PNS System$260
- WaveWriter Alpha Prime 16$245
- Vanta$213
- Evoke SCS$174
- VANTA ADAPTIVESTIM$167
- SYNCHROMEDII$146
- Infinion 16$130
- Stimulan$121
- Eon Family of SCS IPGs$120
How this compares
$63,398 in reported general payments places this provider in the 80th percentile of 149 neurological surgery providers in Colorado.
Other neurological surgery in Denver
- Sean MarkeyDenver$170K
- Edward MaaDenver$165K
- Jens Peter WittDenver$74K
- Benjamin RubinDenver$24K
- Sharad RajpalBoulder$2.8M
- Chad PrusmackLone Tree$2.1M
- Timothy WirtFort Collins$581K
- Donn TurnerFort Collins$581K
- Ernest BraxtonEdwards$549K
- Bradley DuhonLone Tree$386K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.